Free Trial
→ Is President Trump Lying To You With This? (From Colonial Metals) (Ad) Buy DRMA Stock  Free DRMA Stock Alerts

Dermata Therapeutics (DRMA) SEC Filings & 10K Form

Dermata Therapeutics logo
$0.77 -0.04 (-4.67%)
Closing price 05/21/2025 03:54 PM Eastern
Extended Trading
$0.78 +0.01 (+0.75%)
As of 04:24 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Dermata Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
05/21/2025
8:00 AM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2025
4:20 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
2:26 PM		ARMISTICE CAPITAL, LLC (Filed by)
Dermata Therapeutics (Subject)
Dermata Therapeutics, Inc. (Subject)
Form SCHEDULE 13G/A
05/14/2025
8:00 AM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2025
8:01 AM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
11:15 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form EFFECT
04/15/2025
7:30 AM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2025
8:37 PM		Dermata Therapeutics (Subject)
Dermata Therapeutics, Inc. (Subject)
PROEHL GERALD T (Filed by)
Form SCHEDULE 13D/A
04/03/2025
5:00 PM		Dermata Therapeutics (Subject)
Dermata Therapeutics, Inc. (Subject)
PROEHL GERALD T (Filed by)
Form SCHEDULE 13D/A
03/28/2025
4:01 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2025
7:00 AM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2025
4:29 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
3:15 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/17/2025
3:17 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:41 PM		ARMISTICE CAPITAL, LLC (Filed by)
Dermata Therapeutics (Subject)
Dermata Therapeutics, Inc. (Subject)
Form SCHEDULE 13G/A
02/13/2025
5:00 PM		Dermata Therapeutics (Subject)
Dermata Therapeutics, Inc. (Subject)
PROEHL GERALD T (Filed by)
Form SCHEDULE 13D/A
02/05/2025
11:15 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form EFFECT
02/05/2025
4:30 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 424B3
02/04/2025
3:22 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form D/A
01/30/2025
3:09 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/28/2025
4:25 PM		Dermata Therapeutics (Subject)
Dermata Therapeutics, Inc. (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SCHEDULE 13G
01/28/2025
4:00 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
01/23/2025
8:54 PM		Dermata Therapeutics (Subject)
Dermata Therapeutics, Inc. (Subject)
PROEHL GERALD T (Filed by)
Form SCHEDULE 13D/A
01/23/2025
4:00 PM		Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
HALE DAVID F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:02 PM		Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
PROEHL GERALD T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:03 PM		Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
Van Hoose Kyri K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:04 PM		Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
FISHER MARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:16 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
7:05 AM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
5:56 PM		Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
WIERENGA WENDELL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:56 PM		Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
HALE DAVID F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:56 PM		Bedoya-Toro Munera Maria E (Reporting)
Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:57 PM		Bradrick Brittany (Reporting)
Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:57 PM		Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
Nardo Christopher J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:58 PM		Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
Sandler Andrew Seth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:49 PM		Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
Scott Kathleen D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:50 PM		Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
Mento Steven J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:50 PM		Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
PROEHL GERALD T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:50 PM		Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
Van Hoose Kyri K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:50 PM		Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
FISHER MARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
3:16 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
AI Meltdown Imminent: Dump These Stocks Now! (Ad)

If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.

Click here to see the details and learn how to prepare for the next AI revolution
09/27/2024
4:00 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
09/24/2024
11:15 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form EFFECT
09/24/2024
3:16 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 424B3
09/19/2024
3:46 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/17/2024
4:25 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
3:49 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/14/2024
11:15 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form EFFECT
06/07/2024
4:09 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 424B5
06/07/2024
4:11 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
8:02 AM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
3:06 PM		Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:DRMA) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
The DOJ Just Said Your Money Isn’t Yours
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...
Priority Gold | Sponsored
The Prophet's Newest Prediction
A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...
Stansberry Research | Sponsored
A new financial chapter
Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...
Porter & Company | Sponsored
The Secret Map of America, Declassified…
Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...
Banyan Hill Publishing | Sponsored
Trump’s Bitcoin Reserve is No Accident…
How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...
Crypto 101 Media | Sponsored
How I profit during chaos…
This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...
Brownstone Research | Sponsored